Combining Lifestyle With Metformin to Reduce Dementia Risk: Updates From MET-FINGER Trial

Abstract

MET-FINGER is the first randomized controlled trial combining healthy lifestyle changes with a putative disease-modifying drug (metformin) for the prevention of cognitive impairment, in an APOEε4-enriched at-risk population of older adults.